Adler, Michael

Publishing since 1974 (Dinosaur)

Has published 247 publications in 37 years

Number of publications published per year by Adler, Michael. (Source : PubMed)

Distribution of publications types for Adler, Michael. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Adler M, Polinkovsky M, Gutierrez E, Groisman A. Generation of oxygen gradients with arbitrary shapes in a microfluidic device.  Lab Chip  2010;10;3  
•  Hoffmann D, Adler M, Vaidya V, Rached E, Mulrane L, Gallagher WM, Callanan JJ, Gautier JC, Matheis K, Staedtler F, Dieterle F, Brandenburg A, Sposny A, Hewitt P, Ellinger-Ziegelbauer H, Bonventre JV, Dekant W, Mally A. Performance of novel kidney biomarkers in preclinical toxicity studies.  Toxicol. Sci.  2010  
•  Pradat P, Trepo E, Potthoff A, Bakshi R, Young B, Trepo C, Lagier R, Moreno C, Lemmers A, Gustot T, Degre D, Adler M, Wedemeyer H. The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.  Hepatology  2010;51;1  
•  Moreno C, Deltenre P, Pawlotsky JM, Henrion J, Adler M, Mathurin P. Shortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: A meta-analysis.  J. Hepatol.  2009  
•  Adler M, Van Laethem JL, Franchimont D, Zalcman M, Van de Stadt J, Van Gossum A. [Organized colorectal screening in French Community of Belgium and polyp surveillance]  Rev Med Brux  2009;30;4  
•  Langlet P, D'Heygere F, Henrion J, Adler M, Delwaide J, Van Vlierberghe H, Mulkay JP, Lasser L, Brenard R, Horsmans Y, Michielsen P, Laureys A, Nevens F. Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients.  Aliment. Pharmacol. Ther.  2009;30;4  
•  Sieber M, Hoffmann D, Adler M, Vaidya VS, Clement M, Bonventre JV, Zidek N, Rached E, Amberg A, Callanan JJ, Dekant W, Mally A. Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity.  Toxicol. Sci.  2009;109;2  
•  Polus M, Stibbe G, Van Laethem JL, Adler M, Coche E. [Colorectal cancer screening: an absolute necessity and an imminent reality in the French community]  Rev Med Brux  2009;30;3  
•  Adler M, Müller K, Rached E, Dekant W, Mally A. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity.  Carcinogenesis  2009;30;4  
•  Horsmans Y, Colle I, Van Vlierberghe H, Langlet P, Adler M, Bourgeois N, Brenard R, Michielsen P, Goossens A, Bruckers L. Weekly pegylated interferon alpha-2b vs daily interferon a-2b versus standard regimen of interferon a-2b in the treatment of patients with chronic hepatitis C virus infection.  Acta Gastroenterol. Belg.  2008;71;3  

[ See timeline ] [ See all publications ]